erythromycin has been researched along with quinoxalines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaul, M; LaVoie, EJ; Parhi, AK; Pilch, DS; Pradhan, P; Saionz, KW; Trivedi, K; Zhang, Y | 1 |
| Bugaeva, OK; Makarovskaya, LN; Pavlovich, NV; Ryzhkova, VV; Zurabyan, VA | 1 |
2 other study(ies) available for erythromycin and quinoxalines
| Article | Year |
|---|---|
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Naphthyridines; Quinazolines; Quinoxalines; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
[In vitro influence of biologically active factors of microorganisms on antibiotic susceptibility of Yersinia pestis].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Complement Activation; Doxycycline; Erythromycin; Furazolidone; Guinea Pigs; Humans; Microbial Sensitivity Tests; Penicillin G; Penicillins; Plague; Polymyxin B; Quinoxalines; Rifampin; Yersinia pestis | 1997 |